Oftex s.r.o.

Futó vizsgálatok

• Még nem toboroz

  A Phase II/III Multicenter, Randomized, Masked, Active Comparator-Controlled Study to Evaluate the Safety and Efficacy of Two Doses of OCUL101, an Anti-VEGF and Anti-Complement C5, Bi-specific Humanized Antibody-Like “trap” in Participants with Neovascular Age-Related Macular Degeneration with or without Geographic Atrophy – STAT Study

  2026-526648-11-00· 2/3. fázis· Forrás

• Toboroz

  A Study in Adults With Geographic Atrophy

  NCT07606365· 2. fázis· Forrás

• Toboroz

  A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

  NCT07705555· 3. fázis· Forrás

• Toboroz

  A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

  NCT07614776· 3. fázis· Forrás

• Toboroz

  A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

  NCT06962839· 2. fázis· Forrás

• Fut, nem toboroz

  A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF (in patients with Diabetic Macular Edema)

  2024-510944-30-00· 2/3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Időskori makuladegeneráció3 toboroz
• Diabéteszes retinopátia2 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  A Phase 3 Double-masked, Randomized, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema

  2023-507207-66-00· 3. fázis· Forrás

• Lezárult

  A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

  NCT05019521· 2. fázis· Forrás

• Lezárult

  A clinical study of OPT-302 with ranibizumab compared to ranibizumab alone in patients with neovascular age-related macular degeneration

  NCT04757610· 3. fázis· Forrás

• Lezárult

  Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension

  NCT03850782· 3. fázis· Forrás